Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)
Catalog No.
F1618
Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)
Featured Products
Vonlerizumab is a CHO-expressed humanized antibody targeting TNFRSF4/OX40/CD134. Vonlerizumab has a huIgG1-type heavy chain and a huκ-type light chain, with a predicted molecular weight (MW) of 145.22 kDa.
145.22 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
pogalizumab, MOXR0916, RG7888
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P43489
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) is 100%, determined by SEC-HPLC.
TNFRSF4 / OX40 / CD134
Please avoid freeze-thaw cycles.